J. Mark Ray

J. Mark Ray

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
Healthcare
View Bio
RSS

Latest Posts › Medicaid

Share:

Alston & Bird Health Care Week in Review - September 2020 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/14/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medical Devices , Medical Testing , Medicare , Vaccinations

Alston & Bird Health Care Week in Review - September 2020 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/8/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Health Insurance , Hospitals , Medicaid , Medical Devices , Medical Testing , Medicare , Physicians , Public Health , Public Health Emergency , Vaccinations , Virus Testing

Alston & Bird Health Care Week in Review - August 2020 #4

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/31/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medicare , Public Health

Alston & Bird Health Care Week in Review - August 2020 #3

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/24/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medicare , Rural Health Care Providers , Virus Testing

Alston & Bird Health Care Week in Review - August 2020 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/17/2020  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Rural Health Care Providers , SAMHSA

Alston & Bird Health Care Week in Review - August 2020 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/10/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Insurance , Healthcare Facilities , Hospitals , Medicaid , Medicare

Alston & Bird Healthcare Week in Review - July 2020 #5

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/3/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Insurance , Medicaid , Medicare

Alston & Bird Healthcare Week in Review - July 2020 #4

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/27/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Insurance , Medicaid , Medicare

Alston & Bird Healthcare Week in Review - July 2020 #3

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

7/20/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Insurance , Medicaid , Medicare

Alston & Bird Healthcare Week in Review - July 2020 #2

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

7/13/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Insurance , Healthcare , Medicaid , Medicare

Alston & Bird Healthcare Week in Review - July 2020 #1

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

7/6/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid

Alston & Bird Healthcare Week in Review - June 2020 #4

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

6/29/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Telehealth

Alston & Bird Healthcare Week in Review - April 2020 #4

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

4/27/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Health Care Providers , Medicaid , Medicare , Public Health Emergency

Alston & Bird Healthcare Week in Review - April 2020 #3

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

4/20/2020  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Health Care Providers , Medicaid , Medicare , Public Health Emergency

Alston & Bird Healthcare Week in Review

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

6/11/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicaid , Medicare

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

3/25/2019  /  Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , GAO , Medicaid , Medicare , Medicare Part D , OIG

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

8/7/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Health Care Providers , Inpatient Prospective Payment System (IPPS) , Medicaid , Medicare , Prospective Payment System (PPS) , Skilled Nursing Facility

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

7/16/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Durable Medical Equipment , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Physician Fee Schedule , Physicians

Alston & Bird Healthcare Week in Review

Alston & Bird’s Week in Review provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and Congressional committee action; reports, studies, and analyses; and other health...more

6/25/2018  /  Association Health Plans , Biologics , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Department of Labor (DOL) , Employee Benefits , Employee Retirement Income Security Act (ERISA) , Food and Drug Administration (FDA) , Medicaid , Medicare , Opioid , Pharmaceutical Industry , SAMHSA , Substance Abuse

Alston & Bird Healthcare Week in Review

On January 8, 2018, the Department of Veterans Affairs (VA) issued a rule entitled, Reimbursement for Emergency Treatment. The VA revised its regulations concerning payment or reimbursement for emergency treatment for...more

1/15/2018  /  Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare Access and CHIP Reauthorization (MACRA)

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 21, 2016, CMS issued a proposed rule entitled, “Medicare Program: FY 2017 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Requirements.” This...more

4/28/2016  /  1099s , Affordable Care Act , Biologics , Centers for Medicare & Medicaid Services (CMS) , Food and Drug Administration (FDA) , HCPCS , Health Care Providers , Health Savings Accounts , Hospice , HRSA , Inpatient Prospective Payment System (IPPS) , Inpatient Quality Reporting , Inpatient Rehab Facilities , IRS , Legislative Agendas , Long Term Care Facilities , Medicaid , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Medicare Part B , OIG , Opioid , Physician Medicare Reimbursements , Prescription Drugs , SAMHSA , Section 340B , Skilled Nursing Facility , Traumatic Brain Injuries , Veterans

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 15, 2016, the Food and Drug Administration (FDA) issued a proposed rule entitled, “Applications for Approval and Combinations of Active Ingredients Under Consideration for...more

4/21/2016  /  Abbreviated New Drug Application (ANDA) , Affordable Care Act , AHRQ , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , CGMP , Department of Health and Human Services (HHS) , DSCSA , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , HRSA , IRS , Legislative Agendas , Medicaid , Medical Devices , Medicare , OIG , Overpayment , Pharmaceutical Industry , Prescription Drugs , Public Health Insurance Marketplace , Tax Liability

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On April 4, 2016, the Centers for Medicare & Medicaid Services (CMS) issued the Final Calendar Year (CY) 2017 Medicare Advantage Capitation Rates and Medicare Advantage (MA) and...more

4/8/2016  /  Affordable Care Act , Biologics , Cancer , Centers for Medicare & Medicaid Services (CMS) , Department of Veterans Affairs , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Legislative Agendas , Medicaid , Medical Devices , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Medicare Advantage , Medicare Part D , OIG , OMB , Organ Donation , Over The Counter Derivatives (OTC) , Prescription Drugs , Qualified Health Plans , SAMHSA , Vaccinations , Veterans

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On March 29, 2016, Centers for Medicare & Medicaid Services (CMS) issued a final rule entitled, “Medicaid and Children’s Health Insurance Programs: Mental Health Parity and...more

4/1/2016  /  Affordable Care Act , AHRQ , Americans with Disabilities Act (ADA) , Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Controlled Substances Act , Cost-Sharing , Department of Health and Human Services (HHS) , Equal Employment Opportunity Commission (EEOC) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Labeling , Legislative Agendas , Medicaid , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Mental Health , MIPS , OMB , Prescription Drugs , SAMHSA , Substance Abuse , Title I , Vaccinations , Wellness Programs

A&B Healthcare Week in Review

I. REGULATIONS, NOTICES, & GUIDANCE - On March 24, 2016, the Food and Drug Administration (FDA) issued a guidance entitled, “Draft Guidance for Industry: General Principles for Evaluating the Abuse Deterrence of Generic...more

3/25/2016  /  Affordable Care Act , Biologics , Cancer , CCIIO , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , Controlled Substances Act , DEA , Department of Health and Human Services (HHS) , Department of Justice (DOJ) , Food and Drug Administration (FDA) , HCPCS , Legislative Agendas , Medicaid , Medical Devices , Medical Reimbursement , Medicare , Medicare Access and CHIP Reauthorization (MACRA) , Medicare Part D , Native American Issues , Opioid , Pharmaceutical Industry , Prescription Drugs , Public Health Insurance Marketplace , Stem cells , Toxic Exposure , Zika
55 Results
 / 
View per page
« Previous
Page: of 3
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide